These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6407250)

  • 1. Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions.
    Ferrari C; Romussi M; Benco R; Rampini P; Mailland F
    Acta Endocrinol (Copenh); 1983 May; 103(1):1-6. PubMed ID: 6407250
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation.
    Ferrari C; Rampini P; Paracchi A; Boghen M; Mailland F
    Eur J Clin Pharmacol; 1985; 27(6):707-11. PubMed ID: 3921384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin B6 on the serum concentration of pituitary hormones in normal humans and under pathologic conditions.
    Bigazzi M; Ferraro S; Ronga R; Scarselli G; Bruni V; Olivotti AL
    J Endocrinol Invest; 1979; 2(2):117-24. PubMed ID: 573769
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects.
    Ferrari C; Barbieri C; Caldara R; Rampini P; Paracchi A; Boghen M; Rauhe WG
    Clin Pharmacol Ther; 1983 Jul; 34(1):74-8. PubMed ID: 6861440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dopamine on plasma growth hormone and prolactin concentrations under anaesthesia.
    Mikawa K; Kusunoki M; Obara H; Iwai S
    J Int Med Res; 1988; 16(6):403-12. PubMed ID: 3234595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia.
    Sekiya K; Karashima T; Ikuyama S; Muta K; Kato K; Ibayashi H
    Endocrinol Jpn; 1985 Apr; 32(2):207-14. PubMed ID: 4042986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Levels of growth hormone and prolactin in the blood before, during, and after selective transsphenoidal adenectomy in patients with acromegaly and hypophyseal prolactin-producing tumors].
    Sekso M; Vizner B; Reiner Z; Gnjidić Z; Skrablin-Kucić S; Brkić K
    Acta Med Iugosl; 1987; 41(4):229-44. PubMed ID: 3687487
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of naloxone to alter growth hormone and prolactin levels in acromegalic and in hyperprolactinaemic patients.
    Blankstein J; Reyes F; Winter J; Faiman C
    Clin Endocrinol (Oxf); 1979 Nov; 11(5):475-9. PubMed ID: 391445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum gastrin levels in patients with acromegaly.
    Pawlikowski M; Owczarczyk I; Stepień H
    Horm Metab Res; 1981 Dec; 13(12):714-5. PubMed ID: 7319471
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients.
    Verde G; Oppizzi G; Colussi G; Cremascoli G; Botalla L; Müller EE; Silvestrini F; Chiodini PG; Liuzzi A
    Clin Endocrinol (Oxf); 1976 Jul; 5(4):419-23. PubMed ID: 971548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
    Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.
    Hulting AL; Wersäll J; Werner S
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia].
    Sampaolo G; Faloia E; Sarzani R; Bartolacci V; Schiavo P; Butini L; Morosini P
    Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882
    [No Abstract]   [Full Text] [Related]  

  • 14. Modifications in serum growth hormone concentration induced by sulpiride in acromegalic patients pretreated with dopamine, bromocriptine, and metergoline.
    Arosio M; Moriondo P; Travaglini P; Ambrosi B; Beck-Peccoz P; Puglisi FC; Secchi F; Faglia G
    J Clin Endocrinol Metab; 1980 Sep; 51(3):454-61. PubMed ID: 6773973
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegaly with normal growth-hormone levels and pituitary histology. Case report.
    Feingold KR; Goldfine ID; Weinstein PR
    J Neurosurg; 1979 Apr; 50(4):503-7. PubMed ID: 106097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the abnormal response of pituitary somatotropin to dopaminergic drugs in patients with acromegaly].
    Shi YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):168-72. PubMed ID: 2150352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic inhibition of growth hormone and prolactin release during continuous in vitro perifusion of normal and adenomatous human pituitary.
    Lawton NF; Evans AJ; Weller RO
    J Neurol Sci; 1981 Feb; 49(2):229-39. PubMed ID: 7217982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced alterations of the hypothalamus-hypophysis axis.
    Mazzi C; Riva LP; Morandi G; Mainini E; Martinelli I; Bertaccini G
    Acta Psychiatr Belg; 1980; 80(5):619-37. PubMed ID: 7234453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benserazide effects on growth hormone, prolactin, and thyrotropin in normal and acromegalic man.
    Masturzo P; De Maria A; Murialdo G; Bonura ML; Zauli C; Polleri A
    J Clin Endocrinol Metab; 1985 Aug; 61(2):378-81. PubMed ID: 4008612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.